Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as some of the product was somehow contaminated with bacteria along the way before injection in patients. There was a recall, an FDA warning letter, lawsuits, and a voluntary suspension …Read More
John Kosolcharoen
A new film-commercial entitled Awakening pitches unproven exosomes and has already been possibly tied to the troubled stem cell supplier firm Liveyon, but now it seems that the links go far deeper including a possible relative of Liveyon leader John Kosolcharoen. Even so, Kosolcharoen (pictured with another Liveyon leader Alan Gaveck below in a web video) recently denied involvement in an email exchange with me. Awakening drew so much attention in part because of its strong sci-fi vibe and its implication that the exosome …Read More
A new, somewhat mysterious short film that serves as an advertisement for unproven exosomes has some of us scratching our heads. Can you guys as readers of The Niche help solve the puzzle of who’s behind this wild “cinematic commercial” and what the deal is with the unproven exosome product it seemingly promotes as some kind of sci-fi miracle med? I hope so! For more on exosomes and legit research into them see this past guest post. Note that allogeneic exosomes used clinically appear …Read More
Umbilical “stem cell” supplier Liveyon has suspended sales of its products according to the WaPo after a harsh FDA warning letter. While not fully shutting off the tap to the perinatal stem cell clinic universe, as other suppliers including in Utah seem to be continuing, this Liveyon voluntary hold will equal a major reduction in supply. Why did Liveyon chose to halt sales at least for the moment? By comparison other clinic-related firms have continued business as usual despite various FDA actions against them …Read More